IE47539B1 - Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane - Google Patents

Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

Info

Publication number
IE47539B1
IE47539B1 IE2540/78A IE254078A IE47539B1 IE 47539 B1 IE47539 B1 IE 47539B1 IE 2540/78 A IE2540/78 A IE 2540/78A IE 254078 A IE254078 A IE 254078A IE 47539 B1 IE47539 B1 IE 47539B1
Authority
IE
Ireland
Prior art keywords
composition according
bis
bicarbonate
weight
tablet
Prior art date
Application number
IE2540/78A
Other languages
English (en)
Other versions
IE782540L (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IE782540L publication Critical patent/IE782540L/xx
Publication of IE47539B1 publication Critical patent/IE47539B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE2540/78A 1977-12-23 1978-12-21 Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane IE47539B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53825/77A GB1595220A (en) 1977-12-23 1977-12-23 Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

Publications (2)

Publication Number Publication Date
IE782540L IE782540L (en) 1979-06-23
IE47539B1 true IE47539B1 (en) 1984-04-18

Family

ID=10469110

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2540/78A IE47539B1 (en) 1977-12-23 1978-12-21 Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

Country Status (18)

Country Link
JP (1) JPS5489016A (fr)
AU (1) AU523616B2 (fr)
BE (1) BE872918A (fr)
CA (1) CA1108992A (fr)
CH (1) CH641349A5 (fr)
DE (1) DE2855001A1 (fr)
DK (1) DK568278A (fr)
FI (1) FI783897A7 (fr)
FR (1) FR2412310A1 (fr)
GB (1) GB1595220A (fr)
IE (1) IE47539B1 (fr)
IL (1) IL56239A (fr)
IT (1) IT7831068A0 (fr)
LU (1) LU80721A1 (fr)
NL (1) NL7812344A (fr)
NZ (1) NZ189255A (fr)
SE (1) SE7813062L (fr)
ZA (1) ZA787155B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116017B2 (ja) * 1986-05-17 1995-12-13 アース製薬株式会社 入浴剤
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
JP2004514732A (ja) * 2000-12-06 2004-05-20 ファルマシア・コーポレーション 迅速に分散する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2132521A1 (en) * 1971-04-06 1972-11-24 Sofrader Sa Effervescent tablets prdn - by controlled drying in effervescent granule formation
GB1423985A (en) * 1972-02-15 1976-02-04 Fisons Ltd Pharmaceutical compositions containing bischromonyloxy compounds
GB1517153A (en) * 1974-11-30 1978-07-12 Fisons Ltd Naphthopyran-and benzodipyran-2-carboxylic acids and derivatives thereof
GB1570993A (en) * 1976-05-21 1980-07-09 Fisons Ltd Pharmaceutical tablet formulation
GB1557082A (en) * 1977-01-25 1979-12-05 Fisons Ltd Pharmaceutical mixture containing an antiinflammatory

Also Published As

Publication number Publication date
NL7812344A (nl) 1979-06-26
NZ189255A (en) 1984-05-31
ZA787155B (en) 1979-12-27
AU4265478A (en) 1979-06-28
IT7831068A0 (it) 1978-12-20
SE7813062L (sv) 1979-06-24
FI783897A7 (fi) 1979-06-24
IE782540L (en) 1979-06-23
IL56239A0 (en) 1979-03-12
JPS5489016A (en) 1979-07-14
DE2855001A1 (de) 1979-07-05
AU523616B2 (en) 1982-08-05
FR2412310B1 (fr) 1982-12-31
BE872918A (fr) 1979-06-20
IL56239A (en) 1983-02-23
LU80721A1 (fr) 1979-09-07
DK568278A (da) 1979-06-24
CH641349A5 (en) 1984-02-29
GB1595220A (en) 1981-08-12
FR2412310A1 (fr) 1979-07-20
CA1108992A (fr) 1981-09-15

Similar Documents

Publication Publication Date Title
US5656293A (en) Delivery system for enhanced onset and increased potency
KR950002883B1 (ko) 발포성 커플의 제조방법
RU2216317C2 (ru) Композиции симетикон-безводный фосфат кальция
US3138525A (en) Castor wax-amprotropine-resin compositions
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
EP0228164B1 (fr) Composition effervescente contenant de l'ibuprofène
HK1199821A1 (en) Oral pharmaceutical composition
EP0396972B2 (fr) Solution aqueuse de granulation et procédé pour la granulation de comprimés
KR100263284B1 (ko) 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하는 생체 이용률이 개선된 정제
CA2361843C (fr) Comprimes a avaler a teneur elevee en n-acetylcysteine
US5157030A (en) Rapidly soluble aspirin compositions and method
SU1009467A1 (ru) Средство дл растворени мочевых конкрементов
GB1595220A (en) Tablets containing 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane
CA2239331C (fr) Comprimes pharmaceutiques a base de cefuroxime axetil
RU2130310C1 (ru) Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для внутреннего применения
JPH03120257A (ja) 骨形成促進剤
US4465838A (en) Oxaprozin calcium salt
US5043168A (en) Solid choline magnesium salicylate composition and method of preparing same
US20030027837A1 (en) Pharmaceutical compositions comprising quinapril magnesium
US3131121A (en) Highly acidic cation exchange resin containing amprotropine cations
US5399356A (en) Process for making solid dose forms containing bismuth
CA2394902C (fr) Composition effervescente contenant des antagonistes d'histamine h2
KR920008161B1 (ko) 오메프라졸 경구용 약제의 제조방법
JPH09176027A (ja) 医薬組成物
JP2545479B2 (ja) 医薬組成物